Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nihon Shokakibyo Gakkai Zasshi ; 112(2): 297-306, 2015 Feb.
Artículo en Japonés | MEDLINE | ID: mdl-25748156

RESUMEN

A 70-year-old man presented with septic shock and abdominal pain during treatment of pain caused by stage IV lung adenocarcinoma. CT revealed air collection from the retroperitoneum to the muscle around the thigh. Septic shock due to retroperitoneal penetration from the digestive tract was suspected. Despite treatment attempts, the patient died. The autopsy diagnosis was penetration of a sigmoid colon diverticulum under the serosa. When a diverticulum is located near the mesenterium and the size of penetration is small, the air collection rather than fecal matter is likely to extend retroperitoneally. Abdominal pain is little manifest in the penetration in contrast to perforation into abdominal cavity, and the attention is needed.


Asunto(s)
Colon Sigmoide , Divertículo del Colon/patología , Perforación Intestinal/patología , Choque Séptico/etiología , Adenocarcinoma/fisiopatología , Humanos , Neoplasias Pulmonares/fisiopatología , Masculino , Persona de Mediana Edad , Manejo del Dolor
2.
Nihon Shokakibyo Gakkai Zasshi ; 112(3): 537-46, 2015 03.
Artículo en Japonés | MEDLINE | ID: mdl-25759229

RESUMEN

For symptom alleviation, subcutaneous continuous injection of octreotide was administered to a patient with pancreatic neuroendocrine tumor (NET) accompanied by multiple hepatic metastases and ascites. The level of the tumor marker neuron-specific enolase decreased to the normal range and cystic necrosis of the tumors was confirmed. There have been some reports on the antineoplastic effects of octreotide on pancreatic NET; therefore, octreotide appears to be a valid option as a therapeutic agent in patients with highly advanced pancreatic NET, in whom administration of molecular targeted or anticancer agents is difficult because of a poor general status.


Asunto(s)
Antineoplásicos Hormonales/uso terapéutico , Biomarcadores de Tumor/sangre , Neoplasias Hepáticas/tratamiento farmacológico , Tumores Neuroendocrinos/tratamiento farmacológico , Octreótido/uso terapéutico , Neoplasias Pancreáticas/tratamiento farmacológico , Neoplasias Pancreáticas/patología , Humanos , Inyecciones Subcutáneas , Neoplasias Hepáticas/secundario , Masculino , Persona de Mediana Edad , Tumores Neuroendocrinos/sangre , Tumores Neuroendocrinos/secundario
3.
Gan To Kagaku Ryoho ; 40(6): 789-92, 2013 Jun.
Artículo en Japonés | MEDLINE | ID: mdl-23863660

RESUMEN

This paper presents a woman in her 70's with G-CSF producing anaplastic carcinoma of the pancreas(Stage IVb)who underwent chemotherapy by S-1 alone. On FDG-PET after the first course, accumulation of FDG was impaired remarkably. After the second course, the patient died of carcinomatous pleuritis and peritonitis on the 88th day after initiation of treatment. G-CSF producing anaplastic carcinoma of the pancreas is extremely rare and there are no reports with regard to response evaluation by FDG-PET. Thus, this case has significant clinical value.


Asunto(s)
Antimetabolitos Antineoplásicos/uso terapéutico , Carcinoma/diagnóstico por imagen , Ácido Oxónico/uso terapéutico , Neoplasias Pancreáticas/diagnóstico por imagen , Tomografía de Emisión de Positrones , Tegafur/uso terapéutico , Anciano , Autopsia , Carcinoma/tratamiento farmacológico , Carcinoma/metabolismo , Combinación de Medicamentos , Resultado Fatal , Femenino , Fluorodesoxiglucosa F18 , Factor Estimulante de Colonias de Granulocitos/biosíntesis , Humanos , Neoplasias Pancreáticas/tratamiento farmacológico , Neoplasias Pancreáticas/metabolismo , Pleuresia/etiología
4.
Nihon Shokakibyo Gakkai Zasshi ; 109(12): 2088-96, 2012 Dec.
Artículo en Japonés | MEDLINE | ID: mdl-23221058

RESUMEN

A 37-year-old man underwent lobectomy of the right liver for granulocyte colony-stimulating factor (G-CSF) producing hepatocellular carcinoma accompanying type B hepatitis. Within two months after the surgery, lung metastases were revealed and administration of sorafenib was begun, however, the lung metastases continued to enlarge. Changing the patient's medication to tegafur-uracil provided remarkable reduction of the lung metastases. The patient is alive two years after diagnosis and receives outpatient chemotherapy. We concluded that this case is valuable with regard to the extreme rarity of G-CSF producing hepatocellular carcinoma and its successful treatment in this case.


Asunto(s)
Antimetabolitos Antineoplásicos/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma Hepatocelular/tratamiento farmacológico , Factor Estimulante de Colonias de Granulocitos/biosíntesis , Hepatitis B Crónica/complicaciones , Neoplasias Hepáticas/tratamiento farmacológico , Tegafur/administración & dosificación , Uracilo/administración & dosificación , Adulto , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA